Advertisement
Advertisement
ENLV
Enlivex Ltd. Ordinary Shares
0.72
USDSponsored
+0.02
+2.37%
May 21, 15:59 UTC -4
Closed
After-Market
0.74
+0.02
+3.44%
ENLV Earnings Reports
Positive Surprise Ratio
ENLV beat 17 of 30 last estimates.
57%
Next Report
Next Week
Date of Next Report
May 25, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/-$0.02
Implied change from Q4 25 (Revenue/ EPS)
--
/-99.75%
Implied change from Q1 25 (Revenue/ EPS)
--
/-86.67%
Enlivex Ltd. Ordinary Shares earnings per share and revenue
On Mar 25, 2026, ENLV reported earnings of -7.85 USD per share (EPS) for Q4 25, missing the estimate of -0.03 USD, resulting in a -25553.59% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +9.09% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.02 USD, with revenue projected to reach -- USD, implying an decrease of -99.75% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ARS Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.53
Actual
-$0.61
Surprise
-13.81%
ProKidney Corp. Class A Ordinary Shares
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+0.57%
Galectin Therapeutics Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.06
Actual
-$0.08
Surprise
-30.72%
NRX Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
$0.29
Actual
-$0.04
Surprise
-113.64%
Incannex Healthcare Limited - ADR
Report Date
May 15, 2026 For Q3 26
Estimate
-$0.94
Actual
-$11.22
Surprise
-1088.38%
VYNE Therapeutics Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.08
Surprise
+56.43%
Wellgistics Health, Inc. Common Stock
Report Date
May 19, 2026 For Q1 26
Estimate
-Actual
-$0.07
Surprise
-
Traws Pharma, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.75
Actual
-$0.53
Surprise
+29.78%
60 Degrees Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.77
Actual
-$1.28
Surprise
-65.12%
AIM ImmunoTech Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.37
Actual
-$0.56
Surprise
-52.53%
FAQ
What were Enlivex Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Enlivex Ltd. Ordinary Shares reported EPS of -$7.85, missing estimates by -25553.59%, and revenue of $0.00, 0% as expectations.
How did the market react to Enlivex Ltd. Ordinary Shares's Q4 2025 earnings?
The stock price moved up 9.09%, changed from $1.10 before the earnings release to $1.20 the day after.
When is Enlivex Ltd. Ordinary Shares expected to report next?
The next earning report is scheduled for May 25, 2026.
What are the forecasts for Enlivex Ltd. Ordinary Shares's next earnings report?
Based on 3
analysts, Enlivex Ltd. Ordinary Shares is expected to report EPS of -$0.02 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement